Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 203
Ph III recruiting: 21
Growth YoY: +3.8%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 401–410 of 410 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00569257	Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors	completed	Phase 2	85	AEterna ZentarisINDUSTRY	2	Dec 13, 2011	clinicaltrials
NCT00249990	Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)	completed	Phase 2	39	University of New MexicoOTHER	1	Jan 7, 2010	clinicaltrials